Raymond G Schlienger
Overview
Explore the profile of Raymond G Schlienger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mansi E, Johnson E, Thorp M, Go A, Lee M, Shen A, et al.
Pharmacoepidemiol Drug Saf
. 2021 Sep;
30(12):1630-1634.
PMID: 34558760
Purpose: Our objective was to calculate the positive predictive value (PPV) of the ICD-9 diagnosis code for angioedema when physicians adjudicate the events by electronic health record review. Our secondary...
2.
Gagne J, Tsacogianis T, Bruce Wirta S, Rogers J, Calado F, Chang C, et al.
J Comp Eff Res
. 2018 Aug;
7(11):1073-1082.
PMID: 30156128
Aim: We examined characteristics of early sacubitril/valsartan users in a large US electronic health records database. Patients & Methods: We identified three cohorts of patients with heart failure (HF): sacubitril/valsartan...
3.
Do T, Seetasith A, Belleli R, Schlienger R, Corda S, Burudpakdee C, et al.
Am J Cardiovasc Drugs
. 2017 Nov;
18(3):205-211.
PMID: 29177815
Introduction: Real-world evidence on the risk of angioedema associated with angiotensin-converting enzyme inhibitors (ACEIs) in patients with heart failure (HF) is scarce. Objective: This non-interventional study aimed to estimate the...
4.
Schlienger R, Korn J, Wehler E, Lopez Leon S, Yeaw J
Am J Cardiovasc Drugs
. 2017 Aug;
17(6):465-474.
PMID: 28779444
Background: A non-interventional study suggested that use of angiotensin-converting enzyme inhibitors (ACEIs) or aliskiren was associated with an angioedema risk three times that of beta-blockers (BBs). Objective: The aim was...
5.
Klungel O, Kurz X, de Groot M, Schlienger R, Tcherny-Lessenot S, Grimaldi L, et al.
Pharmacoepidemiol Drug Saf
. 2016 Apr;
25 Suppl 1:156-65.
PMID: 27038361
Purpose: To assess the impact of a variety of methodological parameters on the association between six drug classes and five key adverse events in multiple databases. Methods: The selection of...
6.
de Groot M, Candore G, Uddin M, Souverein P, Ali M, Belitser S, et al.
Pharmacoepidemiol Drug Saf
. 2016 Apr;
25 Suppl 1:103-13.
PMID: 27038356
Purpose: The purpose of this study is to evaluate the performance and validity of the case-crossover (CCO) and self-controlled case-series (SCCS) designs when studying the association between hip/femur fracture (HF)...
7.
Souverein P, Abbing-Karahagopian V, Martin E, Huerta C, de Abajo F, Leufkens H, et al.
Pharmacoepidemiol Drug Saf
. 2016 Apr;
25 Suppl 1:88-102.
PMID: 27038355
Purpose: Results from observational studies on the same exposure-outcome association may be inconsistent because of variations in methodological factors, clinical factors or health care systems. We evaluated the consistency of...
8.
Reynolds R, Kurz X, de Groot M, Schlienger R, Grimaldi-Bensouda L, Tcherny-Lessenot S, et al.
Pharmacoepidemiol Drug Saf
. 2016 Apr;
25 Suppl 1:5-10.
PMID: 27038353
The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium (PROTECT) initiative was a collaborative European project that sought to address limitations of current methods in the field of...
9.
Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, et al.
Pharmacoepidemiol Drug Saf
. 2015 Jul;
25 Suppl 1:56-65.
PMID: 26149383
Purpose: Studies on drug utilization usually do not allow direct cross-national comparisons because of differences in the respective applied methods. This study aimed to compare time trends in BZDs prescribing...
10.
de Groot M, Schuerch M, de Vries F, Hesse U, Oliva B, Gil M, et al.
Epilepsia
. 2014 Mar;
55(5):666-673.
PMID: 24575970
Objective: The annual prevalence of antiepileptic drug (AED) prescribing reported in the literature differs considerably among European countries due to use of different type of data sources, time periods, population...